Mori T, Tokuhira M, Mori S, Sato N, Miura I, Adachi A, Kuroda H, Tamaru J, Itoyama S, Suzuki H, Abe T, Takeuchi T
Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Ann Hematol. 2001 Oct;80(10):607-10. doi: 10.1007/s002770100368.
Primary lymphoid tumors of the lacrimal sac are quite rare, and all reported cases are of B-cell tumors with good prognosis. To our knowledge, this is the first case of primary natural killer (NK) cell lymphoma of the lacrimal sac. A 55-year-old woman presented with a lacrimal sac tumor, and histological diagnosis of NK cell lymphoma was made. Although disease was initially localized to the right lacrimal sac, it invaded into the adjacent ethmoidal sinus before chemotherapy was initiated (clinical stage IIE). Epstein-Barr virus (EBV)-encoded small RNA (EBER) was detected in lymphoma cells by in situ hybridization. Systemic chemotherapy combined with intrathecal chemotherapy followed by local radiotherapy was performed, and the patient achieved complete remission. However, shortly after completion of chemoradiotherapy, the lymphoma relapsed with rapid systemic dissemination. The disease was refractory to chemotherapy, and the patient eventually succumbed due to sepsis.
泪囊原发性淋巴瘤非常罕见,所有报道的病例均为预后良好的B细胞肿瘤。据我们所知,这是首例泪囊原发性自然杀伤(NK)细胞淋巴瘤。一名55岁女性因泪囊肿瘤就诊,经组织学诊断为NK细胞淋巴瘤。尽管疾病最初局限于右侧泪囊,但在开始化疗前已侵犯至相邻的筛窦(临床IIE期)。通过原位杂交在淋巴瘤细胞中检测到爱泼斯坦-巴尔病毒(EBV)编码的小RNA(EBER)。患者接受了全身化疗联合鞘内化疗,随后进行局部放疗,实现了完全缓解。然而,放化疗结束后不久,淋巴瘤复发并迅速发生全身播散。该疾病对化疗耐药,患者最终因败血症死亡。